BlackRock, Inc. 13D and 13G filings for TherapeuticsMD, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-31 5:49 pm Purchase | 2021-12-31 | 13G | TherapeuticsMD, Inc. TXMD | BlackRock Inc. BLK | 497,896 5.900% | 69,511 (+16.23%) | Filing |
| 2021-02-01 08:23 am Purchase | 2020-12-31 | 13G | TherapeuticsMD, Inc. TXMD | BlackRock Inc. BLK | 428,385 7.100% | 63,203 (+17.31%) | Filing |